Auris Surgical Robotics, Inc. engages in the development of robotics technology for medical applications. The company designs novel dual-arm microsurgical system for ophthalmic surgery. The company has stated that they are planning to expand the applicability of robotics to a broad spectrum of medical procedures. Auris Surgical Robotics' CEO, Dr. Frederic Moll, leads the company with an extensive entrepreneurial background in the field of medicine. In addition to co-founding Auris Surgical Robotics, Dr. Moll founded Intuitive Surgical in 1995 and Hansen Medical in 2002, serving as CEO in both companies. Dr. Moll also co-founded Mako Surgical which was acquired in 2013 by Stryker Corp. Dr. Moll holds a B.A. degree from University of California at Berkeley, an M.S degree in management from Stanford University, and an M.D. degree from University of Washington. The company was incorporated in 2007 and is headquartered in San Carlos, California.
*Based on Preferred Stock Price, Auris Health, Inc. does not have a stock symbol since it is currently private and is yet to have an IPO.
Some data provided by Crunchbase
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Auris Health, Inc. or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.
To learn more about whether you're eligible, typical investment size, company valuation, and share price, request access here.